Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Featured ArticleArticles, Cellular/Molecular

Genetic Labeling Reveals Novel Cellular Targets of Schizophrenia Susceptibility Gene: Distribution of GABA and Non-GABA ErbB4-Positive Cells in Adult Mouse Brain

Jonathan C. Bean, Thiri W. Lin, Anupama Sathyamurthy, Fang Liu, Dong-Min Yin, Wen-Cheng Xiong and Lin Mei
Journal of Neuroscience 1 October 2014, 34 (40) 13549-13566; https://doi.org/10.1523/JNEUROSCI.2021-14.2014
Jonathan C. Bean
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thiri W. Lin
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anupama Sathyamurthy
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anupama Sathyamurthy
Fang Liu
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong-Min Yin
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
3Institute of Brain Functional Genomics, East China Normal University, Shanghai 200062, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Cheng Xiong
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
2Charlie Norwood Veterans Administration Medical Center, Augusta, Georgia 30904, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Mei
1Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912,
2Charlie Norwood Veterans Administration Medical Center, Augusta, Georgia 30904, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Neuregulin 1 (NRG1) and its receptor ErbB4 are schizophrenia risk genes. NRG1-ErbB4 signaling plays a critical role in neural development and regulates neurotransmission and synaptic plasticity. Nevertheless, its cellular targets remain controversial. ErbB4 was thought to express in excitatory neurons, although recent studies disputed this view. Using mice that express a fluorescent protein under the promoter of the ErbB4 gene, we determined in what cells ErbB4 is expressed and their identity. ErbB4 was widely expressed in the mouse brain, being highest in amygdala and cortex. Almost all ErbB4-positive cells were GABAergic in cortex, hippocampus, basal ganglia, and most of amygdala in neonatal and adult mice, suggesting GABAergic transmission as a major target of NRG1-ErbB4 signaling in these regions. Non-GABAergic, ErbB4-positive cells were present in thalamus, hypothalamus, midbrain, and hindbrain. In particular, ErbB4 is expressed in serotoninergic neurons of raphe nuclei but not in norepinephrinergic neurons of the locus ceruleus. In hypothalamus, ErbB4 is present in neurons that express oxytocin. Finally, ErbB4 is expressed in a group of cells in the subcortical areas that are positive for S100 calcium binding protein β. These results identify novel cellular targets of NRG1-ErbB4 signaling.

  • ErbB4
  • Neuregulin
  • NRG1
  • oxytocin
  • S100β
  • serotonin

Introduction

Neuregulin 1 (NRG1) is a trophic factor belonging to a family of proteins containing an EGF domain (Mei and Xiong, 2008; Mei and Nave, 2014). Its function is mediated by ErbB proteins, with ErbB4 being the only autonomous receptor (Guy et al., 1994; Sliwkowski et al., 1994; Garrett et al., 2003). Both NRG1 and ErbB4 are among well-characterized schizophrenia risk genes (Stefansson et al., 2002; Yang et al., 2003; Mei and Xiong, 2008; Mei and Nave, 2014). NRG1-ErbB4 signaling has been implicated in neural development (Flames et al., 2004; Li et al., 2007; Barros et al., 2009; Fazzari et al., 2010; Ting et al., 2011; Li et al., 2012a; Del Pino et al., 2013; Yin et al., 2013b). Both NRG1 and ErbB4 have been shown to regulate synaptic transmission and plasticity. Acute treatment with NRG1 increases GABA release (Woo et al., 2007) and thus inhibits pyramidal neuron firing and long-term potentiation (Huang et al., 2000; Chen et al., 2010; Wen et al., 2010; Li et al., 2012b; Tan et al., 2012).

However, cellular targets of the ErbB4 gene remain controversial. ErbB4 was thought to express in excitatory neurons (Garcia et al., 2000; Huang et al., 2000; Ma et al., 2003; Kwon et al., 2005; Li et al., 2007; Iyengar and Mott, 2008; Barros et al., 2009; Pitcher et al., 2011) and regulate spines and synaptic plasticity via cell-autonomous mechanisms (Gu et al., 2005; Kwon et al., 2005; Li et al., 2007; Pitcher et al., 2011). However, ErbB4 transcripts are enriched in areas where interneurons are concentrated (Lai and Lemke, 1991; Woo et al., 2007), and its protein is expressed in GAD-positive hippocampal neurons (Huang et al., 2000; Woo et al., 2007). ErbB4 is present in newborn and migrating GABAergic interneurons (Yau et al., 2003) and, in adult, in parvalbumin (PV) and somatostatin interneurons (Vullhorst et al., 2009; Chen et al., 2010; Fazzari et al., 2010; Wen et al., 2010; Abe et al., 2011; Neddens et al., 2011; Ting et al., 2011). Recently, ErbB4 was shown to exclusively express in GABAergic interneurons in cortex and hippocampus (Vullhorst et al., 2009; Fazzari et al., 2010). ErbB4 mRNA was also detected in subcortical regions (Ozaki et al., 1997; Ma et al., 1999; Steiner et al., 1999; Bruce et al., 2002; Anton et al., 2004); however, cellular targets remain unclear due to low resolution of in situ hybridization.

To identify neurons or cells where ErbB4 protein is expressed in the brain, we generated ErbB4-reporter mice where tandem-dimer of DsRed (tdTomato) is expressed under the control of ErbB4's promoter. ErbB4-positive cells were characterized with different markers and in hybrid with GAD67::GFP mice. Our results reveal that ErbB4 expression in cortex is restricted to GABAergic interneurons. In subcortical regions, ErbB4 is expressed in neurons or cells that express serotonin (5-HT) or oxytocin, or s100 calcium binding protein β (S100β). Our study identifies novel cellular targets of ErbB4 and suggests a role of NRG1-ErbB4 signaling in metabolism.

Materials and Methods

All experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Georgia Regents University. Mice were housed at 23°C with a 12 h light/dark cycle and food and water available ad libitum.

Generation of ErbB4-reporter and ErbB4-reporter; GAD67::GFP mice.

Mice with targeted knock-in transgenes ErbB4::CreERT2 and Rosa::LSL-tdTomato (Madisen et al., 2010) were purchased from the The Jackson Laboratory (stock #012360 and #007905, respectively). GAD67::GFP mice were a gift from Dr. Yuchio Yanagawa (National Defense Medical College Hospital, Saitama, Japan) (Tamamaki et al., 2003). In ErbB4::CreERT2 mice, CreERT2 was inserted after the stop codon of the ErbB4 gene, following a ribosomal 2A skip (2A). CreERT2 expression is thus controlled by the promoter of the ErbB4 gene and had no effect of ErbB4 expression or function because CreERT2 is expressed as a separate protein (Madisen et al., 2010). Rosa::LSL-tdTomato has a cassette inserted between exon 1 and exon 2 of the Rosa26 gene, which contains the CMV-IE enhancer/chicken β-actin/rabbit β-globin hybrid promoter, a loxP-stop-loxP (LSL), tdTomato red florescent protein and a woodchuck hepatitis virus post-translational regulatory element (Madisen et al., 2010). GAD67::GFP has an enhanced green florescent protein inserted after exon 1 of GAD67 (Tamamaki et al., 2003).

Primers for genotyping PCR were described as follows: ErbB4::CreERT2, 5′-GGGAG GATTG GGAAG ACAAT-3′, 5′-CCTGC AGGAA TACAG CACAA-3′, and 5′-AAAGA TGGGG CTCTT TGACA-3′; Rosa::LSL-tdTomato, 5′-AAGGG AGCTG CAGTG GAGTA-3′, 5′-CCGAA AATCT GTGGG AAGTC-3′, 5′-GGCAT TAAAG CAGCG TATCC-3′, and 5′-CTGTT CCTGT ACGGC ATGG-3′; GAD67::GFP, 5′-GGCAC AGCTC TCCCT TCTGT TTGC-3′, 5′-GCTCT CCTTT CGCGT TCCGA CAG-3′, and 5′-CTGCT TGTCG GCCAT GATAT AGACG-3′. PCR of ErbB4::CreERT2 resulted in a 465 bp product for mice lacking the transgene, a 190 bp product for mice with the transgene and both products for mice with one allele of each. PCR of Rosa::LSL-tdTomato resulted in a 350 bp product for mice lacking the transgene, a 200 bp product for mice with the transgene, and both products for mice with one allele of each. PCR of GAD67::GFP resulted in a 654 bp product for mice lacking the transgene, and both a 265 bp and 654 bp product for mice heterozygotic for the transgene. Mice with two copies of GAD67::GFP are not viable and are thus were not used.

Breeding ErbB4::CreERT2 and Rosa::LSL-tdTomato mice generated double-transgenic ErbB4::CreERT2; Rosa::LSL-tdTomato mice (hereafter referred as ErbB4-reporter mice). On postnatal day 1 (P1) and postnatal day 60 (P60) mice were administered with 180 mg/kg tamoxifen, once orally and intraperitoneally, every other day over 5 d, respectively, and euthanized at P7 and P70, respectively. Tamoxifen activates CreERT2 in ErbB4-expressing cells and subsequent Cre-mediated removal of the stop signal in the LSL-tdTomato transgene. Ensuing tdTomato expression enabled detection of ErbB4-positive neurons. Five days after the final tamoxifen injection, mice were euthanized and brains were harvested. All experiments were performed on male mice.

Neuron culture.

Neurons were prepared from embryonic day 18 (E18) ErbB4::CreERT2; Rosa::LSL-tdTomato mouse embryos and cultured in neurobasal medium (catalog #21103-049; Invitrogen) supplemented with B27 (catalog #17504-044; Invitrogen), 600 μm l-glutamine (catalog #25-005-CI; Cellgro), and penicillin-streptomycin (catalog #30-003-CI; Cellgro). For low-density culture, 2.5 × 104 cells were seeded on a glass coverslip (1.8 cm in diameter; catalog #12-545-84; Fisher Scientific) coated for 12 h with 1 μg/ml poly-L-lysine (catalog #P2636; Sigma) in 12 well plates (catalog #CLS3513-50EA, Sigma). At day in vitro (DIV) 7, neurons were treated with 2 μm tamoxifen for 1–3 h and fixed for at DIV 12.

Neurons were fixed in 4% PFA at room temperature for 20 min. Neurons were washed 3 times in PBS (10 min each) and incubated (10 min) in 0.3% Triton/PBS. Next, neurons were incubated in 10% goat serum for 1 h and with primary antibody for 24 h at 4°C (Table 1). After washing 3 times in PBS (10 min each), neurons were incubated with AlexaFluor-488 anti-mouse or rabbit antibody (Invitogen) for 1 h at room temperature. Neurons were washed 3 times in PBS before being mounted on Superfrost Plus Microscope Slides (Fisher Scientific) and sealed with Vectasheild Mounting Media (Vector). Images were taken using a Zeiss LSM 710 scanning confocal microscope under a 40 × oil-immersion objective.

View this table:
  • View inline
  • View popup
Table 1.

Antibodies used in the study

Analysis of ErbB4-positive cells.

After being anesthetized with a ketamine (100 mg/kg)/xylazine (10 mg/kg) mixture, mice were transcardially perfused with PBS (2 ml/g of body weight), followed by 4% PFA in PBS. Brains were harvested, incubated in 4% PFA overnight, and dehydrated at 4°C in two steps with 15% and 30% sucrose in PBS. Brains were frozen in OCT (catalog #14-373-65; Fisher) and sectioned into 25 μm slices on a cryostat microtome (Bosch Microm HM550) at −20°C. Slices were collected serially into 24 well plates in a cryoprotective solution (30% propylene glycol, 30% glycerin, and 40% PBS) and stored at −20°C until microscopy studies. Coronal brain slices from ∼3.08 to 2.58 mm relative to bregma were used to access frontal association cortex, 0.74 to −1.94 mm relative to bregma to access primary somatosensory cortex, and −1.34 to −2.18 mm relative to bregma to access dorsal hippocampus.

Every 24th slice (one from each 24 well plate), 575 μm apart, was selected for analysis of ErbB4-positive cell density. Slices were first washed 3 times in PBS for 10 min each, mounted on Superfrost Plus Microscope Slides (Fisher Scientific), and sealed with Vectasheild Mounting Media (Vector) and Premium Cover Glass (Fisher Scientific). Images were taken on a Zeiss LSM 710 scanning confocal microscope with automated stage using a 20 × air objective and stitched together to make complete images of a brain region or section. Brain regions were identified by using anatomical atlases (Paxinos and Franklin, 2001; Lein et al., 2007). For cortical and hippocampal slices, layers were discerned by differences in neuropil and with the aid of anatomical atlas (Lein et al., 2007).

To quantify the density of tdTomato-positive cells, slices (25 μm in thickness) of every 575 μm in a given region or nucleus were examined for positive cells. Positive cells were marked using ImageJ software (National Institutes of Health) multipoint tool. The cell density (cell number per mm3) was calculated by the following equation: cell density = number of positive cells of n slices/sum volume of n slices. Brains were divided into 11 major brain regions, which were subdivided to 173 unique regions.

Immunofluorescent labeling.

Coronal sections from −0.58 to −1.22 mm relative to bregma were used to access if ErbB4 was expressed in oxytocin or vasopressin neurons. Coronal sections from −3.08 mm to −3.80 mm relative to bregma were used to determine whether ErbB4 was expressed in dopamine neurons of the ventral tegmental area (VTA) or substantia nigra compacta. Coronal sections from −3.80 mm to −4.72 mm relative to bregma were used to reveal whether ErbB4 was expressed in serotonin neurons of the raphe nuclei. Coronal sections from −5.34 to −5.52 mm relative to bregma were used to determine whether ErbB4 was expressed in norepinephrine neurons of the locus ceruleus. Coronal sections from −0.46 to −6.64 mm relative to bregma were used to access the identity of the non-neuronal cell that expressed ErbB4.

Brain slices were washed 3 times in PBS for 10 min each, blocked in a solution (10% goat serum, 1% BSA, 0.3% Triton) for 1 h at room temperature, and incubated with primary antibodies (Table 1) for 24 h at 4°C. After washing 3 times in PBS for 10 min each, slices were incubated with AlexaFluor-488 or -405 anti-rabbit or mouse antibodies (Invitrogen) for 1 h at room temperature. Slices were washed 3 times in PBS for 10 min each, mounted on Superfrost Plus Microscope Slides (Fisher Scientific) with Vectasheild Mounting Media (Vector), and covered with Premium Cover Glass (Fisher Scientific). Images were taken on Zeiss LSM 710 scanning confocal microscope with automated stage using a 40× oil-immersion objective. They were stitched together for complete view of regions of interest.

Statistical analysis.

ANOVA was used to access variation of ErbB4-positive cell density across and within major brain regions. Regions were compared against an overall score post hoc using Bonferroni correction for multiple comparisons. Data were expressed as mean ± SEM.

Results

Generation and validation of ErbB4-reporter mice

We generated mice that expressed tdTomato (a red florescent protein) specifically in ErbB4-expressing cells by crossing ErbB4::CreERT2 mice, where CreERT2 expression is under the control of endogenous ErbB4 promoter, with Rosa::LSL-tdTomato mice (hereafter referred to as ErbB4-reporter mice) (Madisen et al., 2010). CreERT2 was inactive in the absence of tamoxifen; thus, no tdTomato expression was detected (data not shown). In mice that were treated with tamoxifen, the CreERT2 became active and thus removed the LSL cassette to enable tdTomato expression (Fig. 1A). To determine whether tdTomato is faithfully expressed in cells that express ErbB4, we cultured cortical neurons from ErbB4-reporter mice at E18. Neurons were stained with 0618 antibody, a rabbit polyclonal antibody raised against the intracellular domain of ErbB4. This antibody has been used widely to label ErbB4 in cultured cortical neurons and in brain slices (Zhu et al., 1995; García-Rivello et al., 2005; Ghashghaei et al., 2006; Woo et al., 2007; Chen et al., 2010; Wen et al., 2010; Del Pino et al., 2013). As shown in Figure 1B (solid arrow), cortical neurons expressing tdTomato were stained positive. To further validate ErbB4-positive cells, cortical neurons were stained with another antibody NeoMarker-H4.77.16, a mouse monoclonal antibody that was raised against the extracellular domain of ErbB4 and reacts with ErbB4-expressing neurons (Vullhorst et al., 2009; Neddens and Buonanno, 2011; Neddens et al., 2011). The monoclonal antibody labeled more strongly tdTomato-expressing neurons than tdTomato-negative neurons (Fig. 1C). These observations demonstrate that tdTomato is expressed in neurons that express endogenous ErbB4 and can be used as a faithful indicator of ErbB4-positive neurons. This notion was supported by staining of cortical and hippocampal slices with the 0618 antibody (Fig. 1D,E).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

tdTomato labels ErbB4-expressing neurons. A, Schematic of transgenes ErbB4::CreERT2 and Rosa::LSL-tdTomato. A ribosomal 2A skip followed by an inducible Cre recombinase (Cre) estrogen receptor T2 (ERT2) was inserted after endogenous ErbB4 gene stop codon. A CMV-IE enhancer/chicken β-actin/rabbit β-globin hybrid (CAG) promoter, a loxP (yellow triangles) flanked stop cassette, tdTomato red florescent protein, and a woodchuck hepatitis virus post-translational regulatory element (WPRE) were inserted between exon 1 (Ex1) and exon 2 (Ex2) of Rosa26 gene. After CreERT2 is activated by tamoxifen, the stop cassette is removed from Rosa::LSL-tdTomato, resulting in Rosa::tdTomato, and tdTomato will be expressed in all cells that were expressing ErbB4 at time of induction. tdTomato-positive neurons in culture (B, C) and in brain slices (D, E) of ErbB4-reporter mice reacted to polyclonal, 0618 ErbB4 antibody (B, D, E) and monoclonal NeoMarker-H4.77.16 ErbB4 antibody (C). Arrows indicate neurons labeled by tdTomato and antibody. Arrowheads indicate neurons labeled by tdTomato alone.

Density of ErbB4-positive cells varies across brain regions

We first assessed the global distribution of ErbB4-positive cells in the brain. ErbB4-positive cells were widely expressed but showed obvious regional differences. Numerically, cortex had a higher concentration of positive cells than the overall average (Fig. 2; Table 2). Amygdala had a particular enrichment of ErbB4-positive cells with a significant difference from the overall total (Fig. 2A,B,E). Thalamus, hindbrain, and cerebellum had significantly lower concentrations than that of overall brain (Fig. 2E,G,H). Midbrain had a numerical lower number of ErbB4-positive cells than whole brain (Fig. 2F,G). The density of ErbB4-positive cells in olfactory bulb, basal ganglia, and hypothalamus was similar to that of entire brain (Fig. 2C–E). It is known that LTP is difficult to induce in amygdala presumably because of high GABAergic activity (Tang et al., 1999; Rammes et al., 2000; Siguròsson et al., 2010). Our result may provide an underlying mechanism, considering NRG1-ErbB4 promotion of GABA release (Woo et al., 2007).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Unique distribution of ErbB4-positive cells in brain regions. Images (photographic negatives) of tdTomato florescence in ErbB4-reporter mouse brain slices illustrating overall ErbB4-positive cell expression. Composite images (A) from a sagittal section 1.80 mm lateral from midline; (B) from a sagittal section 2.52 mm lateral from midline; (C) from a coronal section 4.28 mm relative to bregma; (D) from a coronal section 1.54 mm relative to bregma; (E) from a coronal section −1.06 mm relative to bregma; (F) from a coronal section −3.80 mm relative to bregma; (G) from a coronal section −4.36 mm relative to bregma; and (H) from a coronal section −6.24 mm relative to bregma. A, B, Positions of the sagittal sections were indicated by lines a and b in C–H. C–H, Positions of the coronal sections were indicated by lines c–h in A, B. Amyg, Amygdala; BG, basal ganglia; Cb, cerebellum; Cx, cortex; HB, hindbrain; Hp, hippocampus; Hy, hypothalamus; MB, midbrain; OB, olfactory bulb.

View this table:
  • View inline
  • View popup
Table 2.

Density of ErbB4-positive cells in different brain regionsa

Since recent immunolabeling reports demonstrating that ErbB4 is exclusively expressed in GABAergic interneurons in cortex and hippocampus (Vullhorst et al., 2009; Neddens and Buonanno, 2011; Neddens et al., 2011), we began our studies with experiments to test this hypothesis. ErbB4-reporter mice were crossed with mice that expressed GFP under the endogenous promoter of GAD67, which effectively labels all GABAergic cells (Tamamaki et al., 2003). Unexpectedly, we identified many ErbB4-positive cells to be non-GABAergic in subcortical areas. We characterized these cells by immunohistochemical analysis using different antibody markers to elucidate their cell type. In the following, we describe the distribution of ErbB4-positive cells, cellular identity, and functional implications.

Olfactory system

The olfactory system, responsible for the sense of smell, can be divided into several sections: main olfactory bulb, accessary olfactory bulb, and olfactory cortical regions. The main olfactory bulb has five characteristic layers (Fig. 3A,B): the glomerular layer, the most superficial where axons of olfactory neurons form synapses onto dendrites of mitral cells in glomeruli; the outer plexiform layer containing axons and dendrites; the mitral layer where the soma of mitral cells are located; the internal plexiform layer with dendrites and axons; and the granule cell layer composed of granule interneurons (Scott, 2008; Nolte, 2009a). ErbB4-positive cells were localized in all five layers; however, the density was highest in the glomerular layer, followed by the mitral cell layer (Table 3). Moreover, ErbB4-positive cells in the granule cell layer appeared to project into the mitral cell layer as well as the outer plexiform layer (Fig. 3B, arrows). In agreement, ErbB4 is present in migrating neuroblasts in the rostral migratory stream of the developing brain, which go on to populate the olfactory bulb (Anton et al., 2004; Ghashghaei et al., 2006; Long et al., 2007).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

ErbB4-positive cells are enriched in the glomerulus and mitral cell layers of olfactory bulb. A, Diagram of mouse brain sagittal section (top) and coronal sections (middle, bottom). Dashed lines b and c of the sagittal section diagram indicate the position of coronal sections. B, Coronal section of ErbB4-reporter mouse brain, 4.28 mm relative to bregma. Area shown is indicated by the rectangle in the middle panel of A. C, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, 2.68 mm relative to bregma. Area shown is indicated by the rectangle in the bottom panel of A. D, Enlarged image from the boxed area in C. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. 1, Layer 1; 2/3, layers 2 and 3; 5, layer 5; AON, anterior olfactory nucleus; DLO, dorsal lateral orbital cortex; FrA, frontal association cortex; gl, glomerulus layer; gr, granular layer; ipl, inner plexiform layer; LO, lateral orbital cortex; MO, medial orbital cortex; MOB, main olfactory bulb; ml, mitral layer; opl, outer plexiform layer; PrL, prelimbic cortex; VO, ventral orbital cortex.

View this table:
  • View inline
  • View popup
Table 3.

ErbB4-positive cells are enriched in glomerular and mitral layers in the main olfactory bulba

The olfactory bulb relays information to olfactory cortical regions, such as anterior olfactory nucleus, piriform cortex, olfactory tubercle, and dorsal tenia tectum. ErbB4-positive cells were present throughout the olfactory system (Table 4). Most, if not all, ErbB4-positive cells colocalized with GAD67-GFP, indicating they were GABAergic. However, many GAD67-positive cells did not show evidence of being ErbB4-positive, indicating that not all GABAergic neurons in the olfactory system express ErbB4 (Fig. 3C,D).

View this table:
  • View inline
  • View popup
Table 4.

Even distribution of ErbB4-postive cells in olfactory systema

Cortex

The cerebral cortex is the outermost structure of the vertebrate brain, where high-level processing occurs for varied processes, including motor control and sensory perception. There appeared to be more ErbB4-positive cells in the cortex than other brain regions except the amygdala. However, the density of ErbB4-positive cells varied in different cortical regions: with highest in parietal association, primary visual and secondary visual cortices and lowest in frontal association, lateral orbital, and insular cortices (Table 5).

View this table:
  • View inline
  • View popup
Table 5.

Slight variation in density of ErbB4-positive cells in cortexa

The cortex has a well-defined layered structure. We analyzed ErbB4-positive cell distribution in cortical layers of the primary somatosensory cortex (Fig. 4A,B). Among the six layers, ErbB4-positive cells were densest in the external granular/external pyramidal layers (or layer 2/3) that is populated by pyramidal neurons projecting to other cortical areas. Following that were the molecular layer (or layer 1) where apical dendrites of pyramidal neurons are localized; the internal granular layer (or layer 4) where spiny stellate neurons are located; the internal pyramidal layer (or layer 5) that is populated with pyramidal neurons that project to the spinal cord and subcortical areas; and the polymorphic layer (or layer 6) that is composed of morphologically variable excitatory neurons that project to thalamus (Hendry et al., 2008; Nolte, 2009b). Similar distribution was observed in the frontal association cortex (Fig. 3C).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

ErbB4-positive cells in cortex are enriched in layer 2/3, are GABAergic interneurons and positive for PV. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter mouse brain counterstained with anti-PV, −1.58 mm relative to bregma. Area shown is indicated in the rectangle in A. C, Coronal section of the primary somatosensory cortex (SS1) spanning layers 1–6. Area shown is indicated in the rectangle in B. Arrows indicate neurons positive for ErbB4, GAD67, and PV. Empty arrows indicate neurons positive for ErbB4 and GAD67 but not PV. Arrowhead indicates neurons positive for GAD67 and PV but not ErbB4. Empty arrowhead indicates neurons positive for GAD67 alone. *Cells positive for either ErbB4 or PV but not GAD67. CPu, Caudate–putamen; GI/DI, gustatory and digestive cortex; Hp, hippocampus; Hy, hypothalamus; Ins, insular cortex; LV, lateral ventricle; M1, primary motor cortex; M2, secondary motor cortex; Pir, piriform cortex; RS, retrosplenial cortex; SS1, primary somatosensory cortex; SS2, secondary somatosensory cortex; Th, thalamus.

In both neonatal and adult mice, nearly all ErbB4-positive cells were GAD67-positive in various layers of both cortices, suggesting that ErbB4-positive cells are GABAergic interneurons (Figs. 4 and 5; Tables 6 and 7). In adult mice, >40% of ErbB4-positive cells were also positive for PV, indicating that they were basket and chandelier subtypes of interneurons (Fig. 4C; Table 6). However, only a fraction of GAD67-positive cells were positive for ErbB4. In layer 5, for example, 38.1% of GAD67-positive cells were negative for ErbB4 (Fig. 4C; Table 6). These results suggest that a subgroup of GABAergic interneurons in the cortex is a direct target of the NRG1-ErbB4 pathway. Interestingly, higher colocalization rates were observed in layer 1 (≥80%) for both cortices, suggesting a larger role of NRG1-ErbB4's regulatory role in layer 1.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

ErbB4-positive cells in cortex and hippocampus of neonatal mice are GABAergic interneurons. A, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain. Expression of tdTomato was induced on P1 and examined on P7. B, Enlarged area of the squared region in A. Arrows indicate neurons positive for ErbB4 and GAD67. Open arrows indicate neurons positive for GAD67 alone. CA1, CA1 area of hippocampus; DG, dentate gyrus of hippocampus; P1–7, postnatal days 1–7.

View this table:
  • View inline
  • View popup
Table 6.

ErbB4-positive cells in cortex are GABAergic interneurons, many of which are PV-positivea

View this table:
  • View inline
  • View popup
Table 7.

Cells expressing ErbB4 at P1-P7 are GABAergic interneurons in cortex and hippocampusa

Hippocampus

Hippocampus, a seahorse-shaped structure deep to the cortex, is responsible for memory consolidation, retrieval, and spatial navigation (Morris et al., 1982; Zola-Morgan and Squire, 1986). The hippocampus can be divided into cornu ammonis (CA) 1, 2, and 3 areas and the dentate gyrus (DG) (Buzsaki, 2011). Axons and neurons in the hippocampus form a trisynaptic loop. In the perforant pathway, axons from the entorhinal cortex synapse onto granule cells in the granule cell layer of the DG, which relay the information, in the mossy fiber pathway, to pyramidal neurons in CA3. CA3 pyramidal neurons project to CA1 pyramidal neurons in the Schaffer collateral pathway, which project via subiculum back to the entorhinal cortex (Buzsaki, 2011). ErbB4-positive cells are detectable in various regions of the hippocampus at comparable densities, except the subiculum areas (Table 8). In the DG, ErbB4-positive neurons are enriched in the granule cell layer and polymorphic layer, but lower in the molecular layer. ErbB4-positive cell densities varied across the layers of CA1–3 regions (areas of hippocampus). They were localized primarily in stratum pyramidal where pyramidal neurons are concentrated and stratum lacunosum-moleculare where perforant path axons synapse onto distal dendrites of pyramidal neurons. The density was low in stratum oriens where many basket interneurons are found as well as basal dendrites from pyramidal neurons, stratum lucidum where mossy fibers from DG granule cells pass, or stratum radiatum where Schaffer collaterals are contained (Fig. 6B,C). As observed in the cortex, most ErbB4-positive cells in the CA1–3 regions were GAD67-positive, regardless of layers (Fig. 5B,C). A total of 30% of ErbB4-positive cells were positive for PV, whereas 70%–80% of PV-positive cells were positive for ErbB4. In agreement, NRG1 has been shown to suppress LTP via activating ErbB4 in GABAergic neurons (Table 9) (Huang et al., 2000; Woo et al., 2007; Pitcher et al., 2008; Chen et al., 2010; Wen et al., 2010).

View this table:
  • View inline
  • View popup
Table 8.

ErbB4-positive cell densities vary in hippocampusa

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

ErbB4-positive cells in hippocampus are concentrated in stratum pyramidal and are GABAergic interneurons and positive for PV. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain counterstained with anti-PV, −1.58 mm relative to bregma. Area shown is indicated in the rectangle in A. C, Layers of CA1 and DG areas indicated by rectangle in B. Arrows indicate neurons positive for ErbB4, GAD67, and PV. Empty arrows indicate neurons positive for ErbB4 and GAD67 but not PV. Arrowhead indicates neurons positive for GAD67 and PV but not ErbB4. Empty arrowhead indicates neurons positive for GAD67 alone. 3V, Third ventricle; CPu, caudate–putamen; Ect, ectorhinal cortex; gr, granular layer; Hp, hippocampus; Hy, hypothalamus; ml, molecular layer; Pir, piriform cortex; pl, polymorph layer; PRh, perirhinal cortex; PtA, parietal association cortex; slu, stratum lucidum; slm, stratum lacunosum-moleculare; so, stratum oriens; sp, stratum pyramidal; sr, stratum radiatum; RS, retrosplenial cortex; RTN, reticular thalamic nucleus; SS1, primary somatosensory cortex; SS2, secondary somatosensory cortex; Th, thalamus.

View this table:
  • View inline
  • View popup
Table 9.

ErbB4-positive cells in hippocampus are GABAergic interneurons, many of which are PV-positivea

Basal ganglia

Basal ganglia are responsible for modulation of movement and intimately related to reward and motivation. Unique to the rest of the brain, >90% of neurons in the basal ganglia are medium spiny GABAergic neurons. Its nuclei including the caudate–putamen, the nucleus accumbens, and lateral septum receive input from dopaminergic neurons in the substantia nigra and VTA in the midbrain. In addition, nuclei of the basal ganglia receive glutamatergic inputs from motor cortices (to caudate–putamen), from the subthalamic nucleus in the hypothalamus (to globus pallidus), and from the amygdala (to nucleus accumbens) (Mink, 2008; Nolte, 2009d). The motor circuit culminates in inhibitory projections from the internal segment of the globus pallidus to the thalamus where the signal is relayed back to the motor cortices. ErbB4-positive cells were throughout in the basal ganglia but enriched in fundus of striatum, bed nucleus of the stria terminalis, diagonal bands nucleus, and ventral tip of the lateral septum (Fig. 7A,B, arrow; Table 10), suggesting a role of ErbB4 in reward circuitry. Expression of ErbB4 was low in ventral pallidum, caudate–putamen, and globus pallidus. Most ErbB4-positive cells are GABAergic, although many that were positive for GAD67 were not ErbB4-positive (Fig. 7C,D). This suggests that ErbB4-expressing cells were always GABAergic in the basal ganglia but that most GABAergic neurons do not express ErbB4. This disparity was largest in the caudate–putamen (Fig. 7C). The sparsity and randomness of ErbB4-expressing cells suggest that these are most likely interneurons that play a modulatory role and not the principle cells of this area.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

ErbB4-positive cells in the basal ganglia show unique distribution and are GABAergic interneurons. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, 0.98 mm relative to bregma. Area shown is indicated by the rectangle in A. C, Caudate–putamen area indicated by square C′. D, Lateral septum area indicated by square D′. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. AcC, Nucleus accumbens core; AcSh, nucleus accumbens shell; CPu, caudate–putamen; Cx, cortex; DB, diagonal band nucleus; LS, lateral septum; LV, lateral ventricle; Tu, olfactory tubercle.

View this table:
  • View inline
  • View popup
Table 10.

ErbB4-positive cell densities vary in basal gangliaa

Amygdala

Amygdala is implicated in modulation of fear and emotional memory. It has two input pathways. First, information from sensory cortices goes to the basal lateral amygdala, which relays the signal to the central amygdala via the intercalated nucleus (Fig. 8A,B). Neurons in the central amygdala project to monoaminergic cells of the midbrain and hindbrain, and to cells in hypothalamus. Second, the signal from sensory cortices passes from the lateral amygdala to the ventral portion of the basal lateral amygdala or basal amygdala. From here the signal is relayed to the nucleus accumbens. The effect is to modulate arousal and emotional state and encode them into memory associated with certain stimuli (LeDoux, 2008). Among all brain areas, amygdala was the region that had the highest ErbB4-positive cell density (Table 2), in agreement with in situ hybridization analysis (Lai and Lemke, 1991; Woo et al., 2007). In amygdala, ErbB4-positive cell density varied significantly in different subregions: with the highest concentration in the intercalated nucleus (Table 11; Fig. 8B,D). Almost all ErbB4-positive cells in amygdala were GAD67-positive (Fig. 8), except a few cells in the medial amygdala (Fig. 8E). Some GAD67-positive cells were not positive for ErbB4, as observed in other brain regions (Fig. 8C–E). These results suggest that ErbB4-expressing cells in the amygdala are mostly GABAergic interneurons, although not all GABAergic interneurons express ErbB4 and a small population of ErbB4-expressing cells, in particular those in the medial amygdala, are non-GABAergic.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

ErbB4-positive cells in the amygdala are concentrated in the intercalated nucleus. A, Diagram of mouse coronal section. The position is indicated by the dashed line in Figure 6A. B, Amygdala of ErbB4-reporter; GAD67::GFP mouse brain, −1.58 mm relative to bregma. Dashed lines indicate nuclei of the amygdala. Areas in squares C′, D′, and E′ are shown in panels C–E. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. Arrowheads indicate neurons positive for ErbB4 alone. BLA, Basal lateral amygdala; BMA, basal medial amygdala; CeA, central amygdala; Hp, hippocampus; Hy, hypothalamus; IA, intercalated nucleus of the amygdala; MA, medial amygdala; SS1, primary somatosensory cortex; Th, thalamus.

View this table:
  • View inline
  • View popup
Table 11.

ErbB4-positive cells are enriched in the intercalated nucleus and medial amygdala, within the amygdalaa

Thalamus

The dorsal thalamus acts as a relay center for sensory information traveling to and from sensory cortices other than olfaction (Fig. 9A,B). Information from the cerebellum, basal ganglia, and limbic structures is also relayed at the ventral thalamus. ErbB4-positive cell density was low in the thalamus (Figs. 2E and 9B; Table 12). They are mainly distributed in the medial habenula, in agreement with ErbB4 mRNA localization (Lai and Lemke, 1991; Steiner et al., 1999; Bruce et al., 2002; Woo et al., 2007). Only a small fraction of ErbB4-positive cells were GAD67-positive; more appeared to be negative for GAD67. However, almost all GAD67-positive cells in the medial habenula are ErbB4-positive (Fig. 9D). We observed ErbB4-positive cells that are scattered in the central thalamus. Their soma size was small but had radiating processes that look more like glial cells (Fig. 9B,C, asterisks). These cells were positive for S100β but not with GFAP, oligodendrocyte transcription factor, or MBP (Fig. 10). The identity and function of these cells remain unclear. They may be GFAP-negative astrocytes or unidentified oligodendrocytes. They appeared prominent in the thalamus because of low background ErbB4 signal. Careful examination indicated that they were detectable in the hypothalamus, midbrain, and hindbrain (Fig. 9, asterisks, and figures hereafter). The majority of GABAergic neurons in the thalamus are concentrated in the reticular thalamic nucleus that project to inhibit glutamatergic neurons within the thalamus (Hendry et al., 2008; Nolte, 2009f). In agreement, most GAD67-GFP cells were strictly localized in the reticular thalamic nucleus. Previous studies indicated that ErbB4 mRNA was enriched in the nucleus (Lai and Lemke, 1991; Woo et al., 2007). Intriguingly, most GAD67-positive cells were not positive for ErbB4 in the region (Fig. 9C).

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

ErbB4-positive cells are enriched in medial habenula. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Dashed line indicates coronal section position. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, −1.58 mm relative to bregma. Position of the section is indicated by rectangle in A. *ErbB4-positive cells with non-neuronal morphology. C, Reticular thalamic nucleus area indicated by square in B. D, Coronal section of medial habenula, −1.58 mm relative to bregma. Position of the section is indicated by smaller box in A. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. Arrowheads indicate neurons positive for ErbB4 alone. CPu, Caudate–putamen; Ect, ectorhinal cortex; Hp, hippocampus; Hy, hypothalamus; LH, lateral habenula; MH, medial habenula; Th, thalamus; Pir, piriform cortex; PRh, perirhinal cortex; PtA, parietal association cortex; SS1, primary somatosensory cortex; SS2, secondary somatosensory cortex; RS, retrosplenial cortex; RTN, reticular thalamic nucleus.

View this table:
  • View inline
  • View popup
Table 12.

ErbB4-positive cells are enriched in the medial habenula of the thalamusa

Figure 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 10.

S100β was detected in ErbB4-positive cells in thalamus, hypothalamus, midbrain, and hindbrain. A, B, ErbB4-positive cells in thalamus, with small soma and radiating processes. a, b, Enlarged images of ErbB4-postive cells in rectangles in A and B, respectively. These cells were detected in low density in areas, including hypothalamus (Fig. 11), midbrain (Fig. 14), and hindbrain (Fig. 16) as well as thalamus (Figs. 2E and 9B). Arrows indicate cells positive for ErbB4 and S100β. Empty arrows indicate cells positive for S100β and GFAP but negative for ErbB4. Arrowheads indicate cells positive for ErbB4 alone. Olig2, Oligodendrocyte transcription factor 2.

Hypothalamus

The hypothalamus receives input from nearly all sensory modalities and from hippocampus, amygdala, and cingulate cortex. It also contains sensors for blood temperature, sugar, mineral, and hormone levels (Nolte, 2009c). It plays integral roles in regulating metabolism, thermoregulation, sleep, stress response, and sexual behavior. ErbB4-positive cell densities varied in the hypothalamus: apparently high in the paraventricular hypothalamic nucleus (PaVH), dorsal medial hypothalamic nucleus, and posterior hypothalamic nucleus (Figs. 2E and 11A–C; Table 13). The expression profile generally agrees with that of previous in situ reports (Ma et al., 1999; Woo et al., 2007; Lai and Lemke, 1991) As observed in other areas, some, but not all, ErbB4-positive cells in the PaVH and dorsal medial hypothalamic nucleus were positive for GAD67 (Fig 11D) (data not shown). Likewise, some GAD67-positive cells did not express ErbB4. These results suggest that ErbB4-positive cells in the hypothalamus were a mixture of GABAergic interneurons and non-GABAergic cells (Fig 11D). Neurons in the PaVH are known to release oxytocin, a factor implicated in social bonding, sexual response, maternal care, and lactation (Lee et al., 2009). Costaining analysis indicated that ∼50% of oxytocin-expressing cells in the hypothalamus are positive for ErbB4, suggesting that NRG1-ErbB4 signaling may regulate sociality or maternal instincts (Fig. 12A,B,D). In contrast, none of the cells expressing vasopressin, a factor related to oxytocin sometimes opposing its effects, was positive for ErbB4 (Fig. 12C,E) (Keverne and Curley, 2004). Together, these results suggest that the NRG1-ErbB4 signaling may regulate metabolism or other hypothalamus-associated functions.

Figure 11.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 11.

ErbB4-positive cells enriched in the paraventricular and dorsomedial hypothalamic nuclei. A, Diagram of mouse brain sagittal (top) and coronal (middle and bottom) sections. Coronal section positions were indicated by dashed lines b and c. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, −1.06 mm relative to bregma. Area shown is indicated by the rectangle in A middle. Dashed lines indicate hypothalamus nuclei. C, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, −1.58 mm relative to bregma. *ErbB4-positive cells with non-neuronal morphology. Dashed lines indicate hypothalamus nuclei. D, PaVH, enlarged from the area in the square. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. Arrowheads indicate neurons positive for ErbB4 alone. AH, Anterior hypothalamic nucleus; Arc, arcuate nucleus; CPu, caudate–putamen; Cx, cortex; DM, dorsomedial hypothalamic nucleus; Hp, hippocampus; Hy, hypothalamus; LH, lateral hypothalamus; MA, medial amygdala; RTN, reticular thalamic nucleus; Th, thalamus; VM, ventral medial hypothalamic nucleus; ZI, zona incerta.

View this table:
  • View inline
  • View popup
Table 13.

ErbB4-positive cells are enriched in paraventricular hypothalamic nucleusa

Figure 12.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 12.

ErbB4-positive cells colocalize with oxytocin but not vasopressin in the paraventricular hypothalamic nucleus. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, C, Coronal section of ErbB4-reporter mouse brain, −1.06 mm relative to bregma. Shown was the PaVH area, indicated by the rectangle in A. Sections were stained with antibodies against oxytocin (B) or vasopressin (C). D, E, PaVH areas stained with anti-oxytocin (D) or anti-vasopressin (E). Areas shown were indicated by squares in B and C, respectively. Arrows indicate neurons positive for ErbB4 and oxytocin. Empty arrows indicate neurons positive for oxytocin or vasopressin alone. Arrowheads indicate neurons positive for ErbB4 alone. 3V, Third ventricle; CPu, caudate–putamen; Cx, cortex; Hp, hippocampus; Hy, hypothalamus; RTN, reticular thalamic nucleus; Th, thalamus.

Midbrain

The midbrain is located below and behind the cerebral cortex and in front of the hindbrain. In the midbrain, ErbB4-positive cells are clustered in superior colliculus, periaqueductal gray, raphe nuclei, and interpeduncular nucleus (Figs. 13, 14, and 15; Table 14). Overall, most GAD67-positive cells were negative for ErbB4 in midbrain (Fig. 13A,B). Among the cells that were positive for ErbB4, some were GAD67-positive but many were not (Fig. 13C).

Figure 13.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 13.

ErbB4-positive cells in the midbrain. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, −3.08 mm relative to bregma. Dashed lines indicate midbrain nuclei. C, D, Superior colliculus and VTA, indicated by square C′ and D′ in B, respectively. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. Arrowheads indicate neurons positive for ErbB4 alone. Cx, Cortex; Hp, hippocampus; IF, interfascicular nucleus; MM, medial mammillary nucleus; PAG, periaqueductal gray; SC, superior colliculus; SNr, substantia nigra reticular part; SNc, substantia nigra compact part; VTA, ventral tegmental area.

Figure 14.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 14.

ErbB4-positive cells colocalize with TH in midbrain. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter mouse brain, −3.80 mm relative to bregma. *Non-neuronal ErbB4-positive cells. C, D, VTA and SNc, indicated by squares C′ and D′, respectively. Arrows indicate neurons positive for ErbB4 and TH. Empty arrows indicate neurons positive for TH alone. Arrowheads indicate neurons positive for ErbB4 alone. Cx, Cortex; Hp, hippocampus; IPN, interpeduncular nucleus; PAG, periaqueductal gray; PN, pontine nucleus; RLi, rostral linear nucleus; RN, red nucleus; SC, superior colliculus; SNr, substantia nigra reticular part; SNc, substantia nigra compact part; VTA, ventral tegmental area.

Figure 15.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 15.

ErbB4-positive cells colocalize with serotonin neurons in raphe nuclei. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter mouse brain, −4.36 mm relative to bregma. Sections were stained with anti-5-HT antibody (green). C, D, Dorsal raphe of the midbrain and median raphe of the hindbrain, indicated by squares C′ and D′, respectively. Arrows indicate neurons positive for ErbB4 and 5-HT. Empty arrows indicate neurons positive for 5-HT alone. Arrowheads indicate neurons positive for ErbB4 alone. DR, Dorsal raphe; LL, lateral lemniscus; MnR, median raphe; PAG, periaqueductal gray; PN, pontine nucleus; SC, superior colliculus.

View this table:
  • View inline
  • View popup
Table 14.

ErbB4-positive cells are enriched in raphe nuclei in the midbraina

Interestingly, ErbB4-positive cells are localized in regions that are enriched in monoaminergic neurons, including substantia nigra and VTA where dopamine neurons are concentrated (Figs. 13B,D and 14). This is consistent with previous in situ reports that dopamine neurons express ErbB4 (Steiner et al., 1999; Abe et al., 2009; Zheng et al., 2009). The dopaminergic neurons in the substantia nigra pars compacta (SNc) project to the caudate–putamen in the basal ganglia and are implicated in motor control. On the other hand, dopamine neurons in the VTA project to nucleus accumbens for reward and motivation. They also project to cortical and limbic structures for cognition. The serotoninergic neurons in raphe nuclei have been implicated in alertness and mood regulation (Nolte, 2009e). In both VTA and SNc, ∼50% of ErbB4-positive cells were positive for tyrosine hydroxylase (TH), a marker of dopaminergic neurons (Nagatsu, 1995) (Table 15; Fig. 14). Less than 10% of ErbB4-positive cells are GAD67-positive in both regions. However, ErbB4-positive cells accounted for only a fraction (7%–22%) of dopaminergic neurons (Table 15). This is inconsistent with the notion that nearly all dopamine neurons express ErbB4 (Abe et al., 2009; Zheng et al., 2009). These data suggest that ErbB4-expressing cells in the VTA and SNc are often dopaminergic and sometimes GABAergic.

View this table:
  • View inline
  • View popup
Table 15.

ErbB4-positive cells colocalize with monoaminesa

Having found high densities of ErbB4-positive cells in many raphe nuclei, we examined whether they were serotoninergic neurons by staining with anti-5-HT antibody. We focused on the rostral linear and dorsal raphe nuclei of the midbrain and the median raphe nucleus of the hindbrain, where large amounts of 5-HT neurons are located. ErbB4-positive cells were indeed positive for 5-HT, indicating that ErbB4 is expressed in serotoninergic neurons (Fig. 15). Quantitatively, 20%–40% of ErbB4-positive cells were positive for 5-HT; conversely, 10%–30% of 5-HT cells expressed ErbB4 (Table 15). In the raphe nuclei, most GAD67-positive cells were not positive for ErbB4. These data indicate that ErbB4 is expressed in serotoninergic neurons in raphe nuclei, identifying a novel cellular target of NRG1-ErbB4 signaling.

Hindbrain and cerebellum

The density of ErbB4-positive cells was low in the hindbrain, compared with other brain areas (Table 2). In hindbrain, ErbB4-positive cells were concentrated in the median raphe (Fig. 15), parabrachial nucleus, locus ceruleus (Fig. 16), supratrigeminal nucleus, and posterodorsal tegmental area (Table 16).

Figure 16.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 16.

ErbB4-positive cells do not colocalize with TH in the locus ceruleus. A, Diagram of mouse brain sagittal (left) and coronal (right) sections. Coronal section position is indicated by the dashed line at left. B, Coronal section of ErbB4-reporter mouse brain, −5.34 mm relative to bregma. Sections were stained with anti-TH antibody (green). *ErbB4-positive non-neuronal cells. C, Locus ceruleus, indicated by the square in B. Arrows indicate neurons positive for TH alone. Arrowheads indicate neurons positive for ErbB4 alone. 4V, Fourth ventricle; IC, inferior colliculus; LC, locus ceruleus; Pb, parabrachial nucleus; PCG, pontine central gray.

View this table:
  • View inline
  • View popup
Table 16.

ErbB4-positive cell density varies in hindbrain despite low levelsa

Most of GAD67-positive cells were negative for ErbB4 in hindbrain (Fig. 17A–C). Among the cells that were positive for ErbB4, ∼45% were GAD67-positive, for example, in locus ceruleus (Table 15). Although ErbB4-positive cells in the midbrain could be monoaminergic, those in the hindbrain were negative for TH that marks norepinephrine neurons (Nagatsu, 1995) (Fig. 16; Table 15). These results suggest that ErbB4 expression in monoaminergic neurons is regional specific.

Figure 17.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 17.

ErbB4-positive cells in the cerebellum and hindbrain. A, Diagram of mouse brain sagittal (top) and coronal (bottom) sections. Coronal section position is indicated by the dashed line in top. B, Coronal section of ErbB4-reporter; GAD67::GFP mouse brain, −5.52 mm relative to bregma. C, D, Spinal trigeminal nucleus and simple lobule of cerebellum. Areas shown were indicated by squares C′ and D′ in B. Arrows indicate neurons positive for ErbB4 and GAD67. Empty arrows indicate neurons positive for GAD67 alone. Arrowheads indicate cells positive for ErbB4 alone. 4V, Fourth ventricle; 7N, facial nucleus; Cch, cochlear nucleus; Cul, culmen lobule; Crus 1, Crus 1 of the ansiform lobule; GI, gigantocellular reticular nucleus; IC, inferior colliculus; Ling, lingual lobule; PFI, paraflocculus lobule; RMg, raphe magnus nucleus; Sim, simple lobule; SP5, spinal trigeminal nucleus; Ve, vestibular nucleus.

Previous studies using in situ hybridization suggested that ErbB4 is expressed in the cerebellum (Ozaki et al., 1997, 1998; Rio et al., 1997; Rieff et al., 1999). Compared with other brain areas, ErbB4-positive cells were fewer in the cerebellum (Table 2; Table 17). As shown in Figure 17, GAD67 expression marked Purkinje cells and some smaller interneurons in the granule layer. Occasionally, ErbB4-positive cells were observed in the granule layer. GAD67 signal was not observed in these ErbB4-positive cells (Fig. 17D). These data suggest that GABAergic neurons of the cerebellum may not express ErbB4.

View this table:
  • View inline
  • View popup
Table 17.

Slight variation of ErbB4-positive cell densities in cerebelluma

White matter areas and choroid plexus

ErbB4-positive cells were observed in the white matter, including the corpus callosum (Fig. 18A,B). The positive cell density did not vary across white matter areas (Table 18). Interestingly, most ErbB4-positive cells in the corpus callosum were GAD67-positive. However, there were also cells that were positive for GAD67 but not ErbB4 (Fig. 18B). Finally, large ErbB4-positive cells were observed in the choroid plexus, a tissue that generates the CSF. These mostly colocalized with GAD67 (Fig. 18C).

Figure 18.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 18.

ErbB4-positive cells in the corpus callosum and choroid plexus. A, Diagram of mouse brain coronal sections, −0.94 mm relative to bregma. Coronal section position is indicated by the dashed line in Figure 12A. B, C, Corpus callosum and choroid plexus in the lateral ventricle. Areas shown were indicated by squares B′ and C′, respectively. Arrows indicate cells positive for ErbB4 and GAD67. Empty arrows indicate cells positive for GAD67 alone.

View this table:
  • View inline
  • View popup
Table 18.

ErbB4-positive cells are evenly distributed in white matter areasa

Discussion

The major findings of this study are as follows. First, ErbB4 is widely expressed in the adult mouse brain. Notably ErbB4-positive cell density was highest in the amygdala, followed by the cortex, and by hypothalamus. Expression of ErbB4 in thalamus, hindbrain, and cerebellum was low. Second, ErbB4-positive cells (>98%) were almost always GABAergic in cortex, hippocampus, basal ganglia, and most of amygdala in both neonatal and adult stages, suggesting GABAergic transmission as a major target of NRG1-ErbB4 signaling in these regions. Third, non-GABAergic, ErbB4-positive cells were present in thalamus, hypothalamus, midbrain, and hindbrain. In particular, ErbB4 is expressed in serotoninergic neurons of raphe nuclei but not in norepinephrinergic neurons of the locus ceruleus. In hypothalamus, ErbB4 is present in neurons that express oxytocin. Finally, ErbB4 is expressed in a group of cells that sparsely populate the subcortical areas. Morphologically, they have small soma and short, dense processes and are positive for S100β. These results identify novel cellular targets of NRG1-ErbB4 signaling.

ErbB4 was previously reported to be expressed in excitatory neurons (Garcia et al., 2000; Huang et al., 2000; Ma et al., 2003; Kwon et al., 2005; Li et al., 2007; Iyengar and Mott, 2008; Barros et al., 2009; Pitcher et al., 2011). ErbB4 in excitatory neurons has been implicated in synapse formation and synaptic plasticity through cell-autonomous mechanisms (Gu et al., 2005; Kwon et al., 2005; Li et al., 2007; Pitcher et al., 2011). Contrary to this idea, ErbB4 transcripts were found to be present in areas enriched with interneurons (Lai and Lemke, 1991; Woo et al., 2007). ErbB4 protein was detectable in GAD-positive neurons in the hippocampus (Huang et al., 2000; Woo et al., 2007) and was shown to be exclusively expressed in interneurons (Vullhorst et al., 2009; Fazzari et al., 2010; Neddens and Buonanno, 2011; Neddens et al., 2011). Nevertheless, spine morphology and behavior are impaired by ErbB4 gene mutation via GFAP::Cre, Nestin::Cre, and Emx1::Cre, which are expressed in cells, including pyramidal neurons (Barros et al., 2009). Therefore, it becomes critically important to determine exactly in what cells ErbB4 is expressed. Unfortunately, this question cannot be addressed by current antibodies against ErbB4 because of poor specificity and availability. We attempted to address this question by taking advantage of the endogenous promoter of ErbB4 (Fig. 1). The cells that expressed the tdTomato protein were also labeled by anti-ErbB4 antibodies 0618 and NeoMarker-H4.77.16, validating the feasibility of the approach. Both antibodies showed nonspecific labeling that would make it difficult to interpret data from staining with these antibodies.

ErbB4 protein is expressed in the forebrain areas that are increasingly implicated in schizophrenia, including the amygdala, which is associated with emotional memory (LeDoux, 2008). Schizophrenics often have reduced emotionality or flattened affect (Tsuang et al., 2000) and alteration in amygdala activity (Brunet-Gouet and Decety, 2006; Pinkham et al., 2007; Rasetti et al., 2009). High levels of ErbB4 in amygdala may provide a pathophysiological mechanism of abnormal NRG1-ErbB4 signaling. Finding ErbB4 is primarily expressed in GABA neurons in cortex, hippocampus, and striatum provides further evidence for a role of NRG1 and ErbB4 in the development and function of the GABAergic circuitry. In agreement, ErbB4 is critical for GABAergic neuron migration and differentiation (Flames et al., 2004). NRG1 was shown to promote GABA release and to suppress LTP in a manner that requires ErbB4 (Woo et al., 2007; Chen et al., 2010; Wen et al., 2010). GABAergic dysfunction is well documented in schizophrenia (Gonzalez-Burgos et al., 2011; Lewis et al., 2011). Intriguingly, ErbB4 gene mutation causes schizophrenia-relevant behavior deficits, including hyperactivity, impaired prepulse inhibition, abnormal working memory, and contextual fear conditioning (Stefansson et al., 2002; Chen et al., 2010; Wen et al., 2010; Shamir et al., 2012; Del Pino et al., 2013; Yin et al., 2013a).

Besides interneurons, we found ErbB4-positive cells enriched in the raphe nuclei. They were serotoninergic neurons because they costained with the neurotransmitter (Fig. 15). Serotonin has long been implicated in psychiatric disorders, including schizophrenia (Laruelle et al., 1993; Ngan et al., 2000). This identifies a novel cellular target for NRG1-ErbB4 signaling and adds a layer of complexity to how NRG1 and ErbB4 may be related to the disorder. Moreover, our study reveals that ErbB4-positive cells were enriched in hypothalamic nuclei, including posterior hypothalamic, dorsal medial hypothalamic, PaVH nuclei. In PaVH, ErbB4 was detectable in ∼50% of oxytocin-positive neurons (Fig. 12). Oxytocin is involved in social bonding, sexual arousal, orgasm, maternal care, and lactation (Lee et al., 2009). In light of impaired social interaction in schizophrenia (Tsuang et al., 2000), the finding of ErbB4 in oxytocin-expressing neurons suggests a previously unappreciated pathophysiological mechanism of abnormal NRG1-ErbB4 signaling.

Previous studies suggested that ErbB4 mRNA is enriched in the reticular thalamic nucleus (Lai and Lemke, 1991; Steiner et al., 1999; Bruce et al., 2002; Woo et al., 2007). However, tdTomato signal was not detectable in the reticular thalamic nucleus, except a few cells in the ventral region (Fig. 9). Moreover, ErbB4 mRNA was shown to be in most (80%–99%) dopamine neurons in midbrains of rodents, monkey, and human (Abe et al., 2009; Zheng et al., 2009). In the current study, however, only 20% of midbrain DA neurons expressed tdTomato in ErbB4-reporter mice (Fig. 14). Our result is more consistent with the report of low levels of ErbB4 in dopamine neurons (Neddens and Buonanno, 2011). It is worth pointing out that, in our study, the readout depends on activation of the CreERT2 by tamoxifen that is controlled by tamoxifen bioavailability and expression and stability of the tdTomato protein.

In conclusion, nearly all ErbB4-positive cells were GABAergic in cortex, hippocampus, basal ganglia, and most of amygdala in neonatal and adult mice. This suggests that GABAergic transmission may be a major target of NRG1-ErbB4 signaling in these regions. However, there were non-GABAergic ErbB4-positive cells in subcortical areas, including thalamus, hypothalamus, midbrain, and hindbrain. Intriguingly, ErbB4 was expressed in serotoninergic neurons of raphe nuclei, oxytocin-positive cells in hypothalamus, and glia-like cells that are positive for S100β. These results identify novel cellular targets of NRG1-ErbB4 signaling.

Footnotes

  • This work was supported by the National Institutes of Health (to L.M. and W.-C.X.). We thank Dr. Bo-Shuin Chen for assistance with confocal imaging, Dr. Cary Lai for generously providing us with anti-ErbB4 0618, and Dr. Yuchio Yanagawa for GAD67::GFP mice.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Dr. Lin Mei, Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, 1120 15th Street, CA4006, Augusta GA 30912. lmei{at}gru.edu

References

  1. ↵
    1. Abe Y,
    2. Namba H,
    3. Zheng Y,
    4. Nawa H
    (2009) In situ hybridization reveals developmental regulation of ErbB1–4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 161:95–110, doi:10.1016/j.neuroscience.2009.03.022, pmid:19298847.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Abe Y,
    2. Namba H,
    3. Kato T,
    4. Iwakura Y,
    5. Nawa H
    (2011) Neuregulin-1 signals from the periphery regulate AMPA receptor sensitivity and expression in GABAergic interneurons in developing neocortex. J Neurosci 31:5699–5709, doi:10.1523/JNEUROSCI.3477-10.2011, pmid:21490211.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Anton ES,
    2. Ghashghaei HT,
    3. Weber JL,
    4. McCann C,
    5. Fischer TM,
    6. Cheung ID,
    7. Gassmann M,
    8. Messing A,
    9. Klein R,
    10. Schwab MH,
    11. Lloyd KC,
    12. Lai C
    (2004) Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7:1319–1328, doi:10.1038/nn1345, pmid:15543145.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Barros CS,
    2. Calabrese B,
    3. Chamero P,
    4. Roberts AJ,
    5. Korzus E,
    6. Lloyd K,
    7. Stowers L,
    8. Mayford M,
    9. Halpain S,
    10. Müller U
    (2009) Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc Natl Acad Sci U S A 106:4507–4512, doi:10.1073/pnas.0900355106, pmid:19240213.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Bruce LL,
    2. Kornblum HI,
    3. Seroogy KB
    (2002) Comparison of thalamic populations in mammals and birds: expression of ErbB4 mRNA. Brain Res Bull 57:455–461, doi:10.1016/S0361-9230(01)00678-5, pmid:11923010.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Brunet-Gouet E,
    2. Decety J
    (2006) Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res 148:75–92, doi:10.1016/j.pscychresns.2006.05.001, pmid:17088049.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Buzsaki G
    (2011) Hippocampus. Scholarpedia 6:1468, doi:10.4249/scholarpedia.1468.
    OpenUrlCrossRef
  8. ↵
    1. Chen YJ,
    2. Zhang M,
    3. Yin DM,
    4. Wen L,
    5. Ting A,
    6. Wang P,
    7. Lu YS,
    8. Zhu XH,
    9. Li SJ,
    10. Wu CY,
    11. Wang XM,
    12. Lai C,
    13. Xiong WC,
    14. Mei L,
    15. Gao TM
    (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A 107:21818–21823, doi:10.1073/pnas.1010669107, pmid:21106764.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Del Pino I,
    2. García-Frigola C,
    3. Dehorter N,
    4. Brotons-Mas JR,
    5. Alvarez-Salvado E,
    6. Martínez de Lagrán M,
    7. Ciceri G,
    8. Gabaldón MV,
    9. Moratal D,
    10. Dierssen M,
    11. Canals S,
    12. Marín O,
    13. Rico B
    (2013) Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79:1152–1168, doi:10.1016/j.neuron.2013.07.010, pmid:24050403.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fazzari P,
    2. Paternain AV,
    3. Valiente M,
    4. Pla R,
    5. Luján R,
    6. Lloyd K,
    7. Lerma J,
    8. Marín O,
    9. Rico B
    (2010) Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464:1376–1380, doi:10.1038/nature08928, pmid:20393464.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Flames N,
    2. Long JE,
    3. Garratt AN,
    4. Fischer TM,
    5. Gassmann M,
    6. Birchmeier C,
    7. Lai C,
    8. Rubenstein JL,
    9. Marín O
    (2004) Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44:251–261, doi:10.1016/j.neuron.2004.09.028, pmid:15473965.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Garcia RA,
    2. Vasudevan K,
    3. Buonanno A
    (2000) The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci U S A 97:3596–3601, doi:10.1073/pnas.97.7.3596, pmid:10725395.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. García-Rivello H,
    2. Taranda J,
    3. Said M,
    4. Cabeza-Meckert P,
    5. Vila-Petroff M,
    6. Scaglione J,
    7. Ghio S,
    8. Chen J,
    9. Lai C,
    10. Laguens RP,
    11. Lloyd KC,
    12. Hertig CM
    (2005) Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am J Physiol Heart Circ Physiol 289:H1153–H1160, doi:10.1152/ajpheart.00048.2005, pmid:15863464.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Garrett TP,
    2. McKern NM,
    3. Lou M,
    4. Elleman TC,
    5. Adams TE,
    6. Lovrecz GO,
    7. Kofler M,
    8. Jorissen RN,
    9. Nice EC,
    10. Burgess AW,
    11. Ward CW
    (2003) The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell 11:495–505, doi:10.1016/S1097-2765(03)00048-0, pmid:12620236.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Ghashghaei HT,
    2. Weber J,
    3. Pevny L,
    4. Schmid R,
    5. Schwab MH,
    6. Lloyd KC,
    7. Eisenstat DD,
    8. Lai C,
    9. Anton ES
    (2006) The role of neuregulin-ErbB4 interactions on the proliferation and organization of cells in the subventricular zone. Proc Natl Acad Sci U S A 103:1930–1935, doi:10.1073/pnas.0510410103, pmid:16446434.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gonzalez-Burgos G,
    2. Fish KN,
    3. Lewis DA
    (2011) GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011:723184, doi:10.1155/2011/723184, pmid:21904685.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Gu Z,
    2. Jiang Q,
    3. Fu AK,
    4. Ip NY,
    5. Yan Z
    (2005) Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 25:4974–4984, doi:10.1523/JNEUROSCI.1086-05.2005, pmid:15901778.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Guy PM,
    2. Platko JV,
    3. Cantley LC,
    4. Cerione RA,
    5. Carraway KL 3rd.
    (1994) Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci U S A 91:8132–8136, doi:10.1073/pnas.91.17.8132, pmid:8058768.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Hendry S,
    2. Hsiao SS,
    3. Brown MC
    (2008) in Fundamental neuroscience, Fundamentals of the sensory systems, eds Squire LR, Bloom FE, duLac S, Ghosh A, Spitzer NC (Elsevier, Burlington, MA), Ed 3, pp 535–548.
  20. ↵
    1. Huang YZ,
    2. Won S,
    3. Ali DW,
    4. Wang Q,
    5. Tanowitz M,
    6. Du QS,
    7. Pelkey KA,
    8. Yang DJ,
    9. Xiong WC,
    10. Salter MW,
    11. Mei L
    (2000) Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26:443–455, doi:10.1016/S0896-6273(00)81176-9, pmid:10839362.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Iyengar SS,
    2. Mott DD
    (2008) Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus. Brain Res 1208:67–73, doi:10.1016/j.brainres.2008.02.045, pmid:18387600.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Keverne EB,
    2. Curley JP
    (2004) Vasopressin, oxytocin and social behaviour. Curr Opin Neurobiol 14:777–783, doi:10.1016/j.conb.2004.10.006, pmid:15582383.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Kwon OB,
    2. Longart M,
    3. Vullhorst D,
    4. Hoffman DA,
    5. Buonanno A
    (2005) Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 25:9378–9383, doi:10.1523/JNEUROSCI.2100-05.2005, pmid:16221846.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Lai C,
    2. Lemke G
    (1991) An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6:691–704, doi:10.1016/0896-6273(91)90167-X, pmid:2025425.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Laruelle M,
    2. Abi-Dargham A,
    3. Casanova MF,
    4. Toti R,
    5. Weinberger DR,
    6. Kleinman JE
    (1993) Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arch Gen Psychiatry 50:810–818, doi:10.1001/archpsyc.1993.01820220066007, pmid:8215804.
    OpenUrlCrossRefPubMed
  26. ↵
    1. LeDoux J
    (2008) Amygdala. Scholarpedia 3:2698, doi:10.4249/scholarpedia.2698.
    OpenUrlCrossRef
  27. ↵
    1. Lee HJ,
    2. Macbeth AH,
    3. Pagani JH,
    4. Young WS 3rd.
    (2009) Oxytocin: the great facilitator of life. Prog Neurobiol 88:127–151, doi:10.1016/j.pneurobio.2009.04.001, pmid:19482229.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Lein ES,
    2. Hawrylycz MJ,
    3. Ao N,
    4. Ayres M,
    5. Bensinger A,
    6. Bernard A,
    7. Boe AF,
    8. Boguski MS,
    9. Brockway KS,
    10. Byrnes EJ,
    11. Chen L,
    12. Chen L,
    13. Chen TM,
    14. Chin MC,
    15. Chong J,
    16. Crook BE,
    17. Czaplinska A,
    18. Dang CN,
    19. Datta S,
    20. Dee NR,
    21. et al.
    (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168–176, doi:10.1038/nature05453, pmid:17151600.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Lewis DA,
    2. Fish KN,
    3. Arion D,
    4. Gonzalez-Burgos G
    (2011) Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol 21:866–872, doi:10.1016/j.conb.2011.05.013, pmid:21680173.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Li B,
    2. Woo RS,
    3. Mei L,
    4. Malinow R
    (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54:583–597, doi:10.1016/j.neuron.2007.03.028, pmid:17521571.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Li H,
    2. Chou SJ,
    3. Hamasaki T,
    4. Perez-Garcia CG,
    5. O'Leary DD
    (2012a) Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations. Neural Dev 7:10, doi:10.1186/1749-8104-7-10, pmid:22376909.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Li KX,
    2. Lu YM,
    3. Xu ZH,
    4. Zhang J,
    5. Zhu JM,
    6. Zhang JM,
    7. Cao SX,
    8. Chen XJ,
    9. Chen Z,
    10. Luo JH,
    11. Duan S,
    12. Li XM
    (2012b) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci 15:267–273, doi:10.1038/nn.3006, pmid:22158511.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Long JE,
    2. Garel S,
    3. Alvarez-Dolado M,
    4. Yoshikawa K,
    5. Osumi N,
    6. Alvarez-Buylla A,
    7. Rubenstein JL
    (2007) Dlx-dependent and -independent regulation of olfactory bulb interneuron differentiation. J Neurosci 27:3230–3243, doi:10.1523/JNEUROSCI.5265-06.2007, pmid:17376983.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Ma L,
    2. Huang YZ,
    3. Pitcher GM,
    4. Valtschanoff JG,
    5. Ma YH,
    6. Feng LY,
    7. Lu B,
    8. Xiong WC,
    9. Salter MW,
    10. Weinberg RJ,
    11. Mei L
    (2003) Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J Neurosci 23:3164–3175, pmid:12716924.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Ma YJ,
    2. Hill DF,
    3. Creswick KE,
    4. Costa ME,
    5. Cornea A,
    6. Lioubin MN,
    7. Plowman GD,
    8. Ojeda SR
    (1999) Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development. J Neurosci 19:9913–9927, pmid:10559400.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Madisen L,
    2. Zwingman TA,
    3. Sunkin SM,
    4. Oh SW,
    5. Zariwala HA,
    6. Gu H,
    7. Ng LL,
    8. Palmiter RD,
    9. Hawrylycz MJ,
    10. Jones AR,
    11. Lein ES,
    12. Zeng H
    (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133–140, doi:10.1038/nn.2467, pmid:20023653.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Mei l,
    2. Nave KA
    (2014) Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron 83:27–49, doi:10.1016/j.neuron.2014.06.007, pmid:24991953.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Mei L,
    2. Xiong WC
    (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9:437–452, doi:10.1038/nrn2392, pmid:18478032.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Mink JW
    (2008) in Fundamental neuroscience, The basal ganglia, eds Squire LR, Bloom FE, duLac S, Ghosh A, Spitzer NC (Elsevier, Burlington, MA), Ed 3, pp 725–750.
  40. ↵
    1. Morris RG,
    2. Garrud P,
    3. Rawlins JN,
    4. O'Keefe J
    (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683, doi:10.1038/297681a0, pmid:7088155.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Nagatsu T
    (1995) Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays Biochem 30:15–35, pmid:8822146.
    OpenUrlPubMed
  42. ↵
    1. Neddens J,
    2. Buonanno A
    (2011) Expression of the neuregulin receptor ErbB4 in the brain of the rhesus monkey (Macaca mulatta) PLoS One 6:e27337, doi:10.1371/journal.pone.0027337, pmid:22087295.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Neddens J,
    2. Fish KN,
    3. Tricoire L,
    4. Vullhorst D,
    5. Shamir A,
    6. Chung W,
    7. Lewis DA,
    8. McBain CJ,
    9. Buonanno A
    (2011) Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry 70:636–645, doi:10.1016/j.biopsych.2011.04.016, pmid:21664604.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Ngan ET,
    2. Yatham LN,
    3. Ruth TJ,
    4. Liddle PF
    (2000) Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [(18)F]setoperone. J Psychiatry 157:1016–1018, doi:10.1176/appi.ajp.157.6.1016, pmid:10831488.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Nolte J
    (2009a) The human brain: an introduction to its functional anatomy, The chemical senses of taste and smell (Mosby Elsevier, Philadelphia), Ed 6, pp 323–341.
  46. ↵
    1. Nolte J
    (2009b) The human brain: an introduction to its functional anatomy, Cerebral cortex (Mosby Elsevier, Philadelphia), Ed 6, pp 541–579.
  47. ↵
    1. Nolte J
    (2009c) The human brain: an introduction to its functional anatomy, Drives and emotions: the hypothalamus and the limbic system (Mosby Elsevier, Philadelphia), Ed 6, pp 580–607.
  48. ↵
    1. Nolte J
    (2009d) The human brain: an introduction to its functional anatomy, Basal ganglia (Mosby Elsevier, Philadelphia), Ed 6, pp 474–493.
  49. ↵
    1. Nolte J
    (2009e) The human brain: an introduction to its functional anatomy, Organization of the brainstem (Mosby Elsevier, Philadelphia), Ed 6, pp 266–294.
  50. ↵
    1. Nolte J
    (2009f) The human brain: an introduction to its functional anatomy, The thalamus and internal capsule: gatting to and from the cerebral cortex (Mosby Elsevier, Philadelphia), Ed 6, pp 390–414.
  51. ↵
    1. Ozaki M,
    2. Sasner M,
    3. Yano R,
    4. Lu HS,
    5. Buonanno A
    (1997) Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390:691–694, doi:10.1038/37795, pmid:9414162.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Ozaki M,
    2. Kishigami S,
    3. Yano R
    (1998) Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum. Neurosci Res 30:351–354, doi:10.1016/S0168-0102(98)00013-3, pmid:9678639.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Paxinos G,
    2. Franklin KBJ
    (2001) The mouse brain in stereotaxic coordinates (Academic, San Diego), Ed 2.
  54. ↵
    1. Pinkham AE,
    2. Gur RE,
    3. Gur RC
    (2007) Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications. Expert Rev Neurother 7:807–816, doi:10.1586/14737175.7.7.807, pmid:17610388.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Pitcher GM,
    2. Beggs S,
    3. Woo RS,
    4. Mei L,
    5. Salter MW
    (2008) ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport 19:139–143, doi:10.1097/WNR.0b013e3282f3da10, pmid:18185097.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Pitcher GM,
    2. Kalia LV,
    3. Ng D,
    4. Goodfellow NM,
    5. Yee KT,
    6. Lambe EK,
    7. Salter MW
    (2011) Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med 17:470–478, doi:10.1038/nm.2315, pmid:21441918.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Rammes G,
    2. Steckler T,
    3. Kresse A,
    4. Schütz G,
    5. Zieglgänsberger W,
    6. Lutz B
    (2000) Synaptic plasticity in the basolateral amygdala in transgenic mice expressing dominant-negative cAMP response element-binding protein (CREB) in forebrain. Eur J Neurosci 12:2534–2546, doi:10.1046/j.1460-9568.2000.00108.x, pmid:10947828.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Rasetti R,
    2. Mattay VS,
    3. Wiedholz LM,
    4. Kolachana BS,
    5. Hariri AR,
    6. Callicott JH,
    7. Meyer-Lindenberg A,
    8. Weinberger DR
    (2009) Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. J Psychiatry 166:216–225, doi:10.1176/appi.ajp.2008.08020261, pmid:19074979.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Rieff HI,
    2. Raetzman LT,
    3. Sapp DW,
    4. Yeh HH,
    5. Siegel RE,
    6. Corfas G
    (1999) Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 19:10757–10766, pmid:10594059.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Rio C,
    2. Rieff HI,
    3. Qi P,
    4. Khurana TS,
    5. Corfas G
    (1997) Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 19:39–50, doi:10.1016/S0896-6273(00)80346-3, pmid:9247262.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Scott K
    (2008) in Fundamental neuroscience, Chemical senses: taste and olfaction, eds Squire LR, Bloom FE, duLac S, Ghosh A, Spitzer NC (Elsevier, Burlington, MA), Ed 3, pp 549–580.
  62. ↵
    1. Shamir A,
    2. Kwon OB,
    3. Karavanova I,
    4. Vullhorst D,
    5. Leiva-Salcedo E,
    6. Janssen MJ,
    7. Buonanno A
    (2012) The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J Neurosci 32:2988–2997, doi:10.1523/JNEUROSCI.1899-11.2012, pmid:22378872.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Siguròsson T,
    2. Cain CK,
    3. Doyère V,
    4. LeDoux JE
    (2010) Asymmetries in long-term and short-term plasticity at thalamic and cortical inputs to the amygdala in vivo. Eur J Neurosci 31:250–262, doi:10.1111/j.1460-9568.2009.07056.x, pmid:20074223.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Sliwkowski MX,
    2. Schaefer G,
    3. Akita RW,
    4. Lofgren JA,
    5. Fitzpatrick VD,
    6. Nuijens A,
    7. Fendly BM,
    8. Cerione RA,
    9. Vandlen RL,
    10. Carraway KL 3rd.
    (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661–14665, pmid:7514177.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    1. Stefansson H,
    2. Sigurdsson E,
    3. Steinthorsdottir V,
    4. Bjornsdottir S,
    5. Sigmundsson T,
    6. Ghosh S,
    7. Brynjolfsson J,
    8. Gunnarsdottir S,
    9. Ivarsson O,
    10. Chou TT,
    11. Hjaltason O,
    12. Birgisdottir B,
    13. Jonsson H,
    14. Gudnadottir VG,
    15. Gudmundsdottir E,
    16. Bjornsson A,
    17. Ingvarsson B,
    18. Ingason A,
    19. Sigfusson S,
    20. Hardardottir H,
    21. et al.
    (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877–892, doi:10.1086/342734, pmid:12145742.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Steiner H,
    2. Blum M,
    3. Kitai ST,
    4. Fedi P
    (1999) Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol 159:494–503, doi:10.1006/exnr.1999.7163, pmid:10506520.
    OpenUrlCrossRefPubMed
  67. ↵
    1. Tamamaki N,
    2. Yanagawa Y,
    3. Tomioka R,
    4. Miyazaki J,
    5. Obata K,
    6. Kaneko T
    (2003) Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467:60–79, doi:10.1002/cne.10905, pmid:14574680.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Tan GH,
    2. Liu YY,
    3. Hu XL,
    4. Yin DM,
    5. Mei L,
    6. Xiong ZQ
    (2012) Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci 15:258–266, doi:10.1038/nn.3005, pmid:22158510.
    OpenUrlCrossRefPubMed
  69. ↵
    1. Tang YP,
    2. Shimizu E,
    3. Dube GR,
    4. Rampon C,
    5. Kerchner GA,
    6. Zhuo M,
    7. Liu G,
    8. Tsien JZ
    (1999) Genetic enhancement of learning and memory in mice. Nature 401:63–69, doi:10.1038/43432, pmid:10485705.
    OpenUrlCrossRefPubMed
  70. ↵
    1. Ting AK,
    2. Chen Y,
    3. Wen L,
    4. Yin DM,
    5. Shen C,
    6. Tao Y,
    7. Liu X,
    8. Xiong WC,
    9. Mei L
    (2011) Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci 31:15–25, doi:10.1523/JNEUROSCI.2538-10.2011, pmid:21209185.
    OpenUrlAbstract/FREE Full Text
  71. ↵
    1. Tsuang MT,
    2. Stone WS,
    3. Faraone SV
    (2000) Toward reformulating the diagnosis of schizophrenia. J Psychiatry 157:1041–1050, doi:10.1176/appi.ajp.157.7.1041, pmid:10873908.
    OpenUrlCrossRefPubMed
  72. ↵
    1. Vullhorst D,
    2. Neddens J,
    3. Karavanova I,
    4. Tricoire L,
    5. Petralia RS,
    6. McBain CJ,
    7. Buonanno A
    (2009) Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J Neurosci 29:12255–12264, doi:10.1523/JNEUROSCI.2454-09.2009, pmid:19793984.
    OpenUrlAbstract/FREE Full Text
  73. ↵
    1. Wen L,
    2. Lu YS,
    3. Zhu XH,
    4. Li XM,
    5. Woo RS,
    6. Chen YJ,
    7. Yin DM,
    8. Lai C,
    9. Terry AV Jr.,
    10. Vazdarjanova A,
    11. Xiong WC,
    12. Mei L
    (2010) Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 107:1211–1216, doi:10.1073/pnas.0910302107, pmid:20080551.
    OpenUrlAbstract/FREE Full Text
  74. ↵
    1. Woo RS,
    2. Li XM,
    3. Tao Y,
    4. Carpenter-Hyland E,
    5. Huang YZ,
    6. Weber J,
    7. Neiswender H,
    8. Dong XP,
    9. Wu J,
    10. Gassmann M,
    11. Lai C,
    12. Xiong WC,
    13. Gao TM,
    14. Mei L
    (2007) Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54:599–610, doi:10.1016/j.neuron.2007.04.009, pmid:17521572.
    OpenUrlCrossRefPubMed
  75. ↵
    1. Yang JZ,
    2. Si TM,
    3. Ruan Y,
    4. Ling YS,
    5. Han YH,
    6. Wang XL,
    7. Zhou M,
    8. Zhang HY,
    9. Kong QM,
    10. Liu C,
    11. Zhang DR,
    12. Yu YQ,
    13. Liu SZ,
    14. Ju GZ,
    15. Shu L,
    16. Ma DL,
    17. Zhang D
    (2003) Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 8:706–709, doi:10.1038/sj.mp.4001377, pmid:12874607.
    OpenUrlCrossRefPubMed
  76. ↵
    1. Yau HJ,
    2. Wang HF,
    3. Lai C,
    4. Liu FC
    (2003) Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex 13:252–264, doi:10.1093/cercor/13.3.252, pmid:12571115.
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. Yin DM,
    2. Chen YJ,
    3. Lu YS,
    4. Bean JC,
    5. Sathyamurthy A,
    6. Shen C,
    7. Liu X,
    8. Lin TW,
    9. Smith CA,
    10. Xiong WC,
    11. Mei L
    (2013a) Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron 78:644–657, doi:10.1016/j.neuron.2013.03.028, pmid:23719163.
    OpenUrlCrossRefPubMed
  78. ↵
    1. Yin DM,
    2. Sun XD,
    3. Bean JC,
    4. Lin TW,
    5. Sathyamurthy A,
    6. Xiong WC,
    7. Gao TM,
    8. Chen YJ,
    9. Mei L
    (2013b) Regulation of spine formation by ErbB4 in PV-positive interneurons. J Neurosci 33:19295–19303, doi:10.1523/JNEUROSCI.2090-13.2013, pmid:24305825.
    OpenUrlAbstract/FREE Full Text
  79. ↵
    1. Zheng Y,
    2. Watakabe A,
    3. Takada M,
    4. Kakita A,
    5. Namba H,
    6. Takahashi H,
    7. Yamamori T,
    8. Nawa H
    (2009) Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Prog Neuropsychopharmacol Biol Psychiatry 33:701–706, doi:10.1016/j.pnpbp.2009.03.021, pmid:19336245.
    OpenUrlCrossRefPubMed
  80. ↵
    1. Zhu X,
    2. Lai C,
    3. Thomas S,
    4. Burden SJ
    (1995) Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J 14:5842–5848, pmid:8846777.
    OpenUrlPubMed
  81. ↵
    1. Zola-Morgan S,
    2. Squire LR
    (1986) Memory impairment in monkeys following lesions limited to the hippocampus. Behav Neurosci 100:155–160, doi:10.1037/0735-7044.100.2.155, pmid:3964416.
    OpenUrlCrossRefPubMed
View Abstract
Back to top

In this issue

The Journal of Neuroscience: 34 (40)
Journal of Neuroscience
Vol. 34, Issue 40
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Genetic Labeling Reveals Novel Cellular Targets of Schizophrenia Susceptibility Gene: Distribution of GABA and Non-GABA ErbB4-Positive Cells in Adult Mouse Brain
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Genetic Labeling Reveals Novel Cellular Targets of Schizophrenia Susceptibility Gene: Distribution of GABA and Non-GABA ErbB4-Positive Cells in Adult Mouse Brain
Jonathan C. Bean, Thiri W. Lin, Anupama Sathyamurthy, Fang Liu, Dong-Min Yin, Wen-Cheng Xiong, Lin Mei
Journal of Neuroscience 1 October 2014, 34 (40) 13549-13566; DOI: 10.1523/JNEUROSCI.2021-14.2014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Genetic Labeling Reveals Novel Cellular Targets of Schizophrenia Susceptibility Gene: Distribution of GABA and Non-GABA ErbB4-Positive Cells in Adult Mouse Brain
Jonathan C. Bean, Thiri W. Lin, Anupama Sathyamurthy, Fang Liu, Dong-Min Yin, Wen-Cheng Xiong, Lin Mei
Journal of Neuroscience 1 October 2014, 34 (40) 13549-13566; DOI: 10.1523/JNEUROSCI.2021-14.2014
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • ErbB4
  • Neuregulin
  • NRG1
  • oxytocin
  • S100β
  • serotonin

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Neurophysiological Evidence for a Cortical Contribution to the Wakefulness-Related Drive to Breathe Explaining Hypocapnia-Resistant Ventilation in Humans
  • Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Show more Articles

Cellular/Molecular

  • Cell type-dependent short-term plasticity and dopaminergic modulation of sensory synapses onto mouse superficial dorsal horn neurons
  • Identification of new ciliary signaling pathways in the brain and insights into neurological disorders
  • Stress-sensitization of neurons in the dentate gyrus is dependent on neuronal interleukin-1 receptor signaling and is associated with increased synaptic plasticity, perineuronal nets, and excitatory/inhibitory input imbalance.
Show more Cellular/Molecular
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.